fusion-antibodies
1 known investors
Fusion Antibodies is a contract research provider offering end-to-end antibody development services, from antigen design through cell line development, for organizations advancing therapeutic antibodies toward the clinic. It works as an extension of client teams with attention to manufacturability and commercialization.